Medicare Enrolled

Dr. Nagesh Kohli, M.D.

Pulmonary Disease · Ocala, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1834 SW 1ST AVE, Ocala, FL 34471
3527325552
In practice since 2006 (19 years)
NPI: 1881657732 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kohli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kohli? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kohli

Dr. Nagesh Kohli is a pulmonary disease in Ocala, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kohli performed 1,727 Medicare services across 1,329 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kohli received a total of $24,885 from 27 pharmaceutical and/or device companies across 287 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kohli is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 37% volume in FL$ $24,885 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,727
Medicare services
Top 37% in FL for pulmonary disease
1,329
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~91 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity310$96$180
Office visit, established patient (20-29 min)243$63$138
Office visit, established patient (30-39 min)229$99$190
Hospital follow-up visit, moderate complexity106$64$120
Test to measure expiratory airflow and volume changes before and after medication administration101$29$88
Test to examine how well the lungs exchange gases101$44$67
Initial hospital admission, high complexity84$140$263
Critical care, first 30-74 min84$174$403
Test to determine lung volumes using sensors75$42$65
New patient office visit (45-59 min)59$117$250
Initial hospital admission, moderate complexity54$106$198
Sleep study in sleep lab (6 years or older)28$468$1,000
Test to determine lung volumes using gas dilution or washout26$33$65
Artery puncture collection of blood sample22$19$40
Carboxyhemoglobin (protein) level22$12$25
Blood gases measurement, with o2 saturation22$77$90
Blood potassium level22$5$8
Blood sodium level22$5$8
Blood count, hemoglobin22$2$5
Methemoglobin (hemoglobin) analysis, quantitative21$8$9
Test for exercise-induced lung stress20$25$60
Irrigation and suction of lung airways to obtain cells using an endoscope14$62$340
Sleep study in sleep lab with continuous airway pressure (6 years or older)14$487$1,200
Smoking and tobacco use intensive counseling, 4-10 minutes14$15$22
New patient office visit, complex (60-74 min)12$176$330
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$24,885
Total received (2018-2024)
Avg $3,555/year across 7 years
Top 10% in FL for pulmonary disease
27
Companies
287
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21,191 (85.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,695 (14.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$112
2023
$798
2022
$711
2021
$2,209
2020
$5,795
2019
$3,636
2018
$11,625

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$17,400
GlaxoSmithKline, LLC.
$5,138
AstraZeneca Pharmaceuticals LP
$414
Intuitive Surgical, Inc.
$255
Philips Electronics North America Corporation
$235
Genentech USA, Inc.
$216
GENZYME CORPORATION
$215
Actelion Pharmaceuticals US, Inc.
$174
Grifols USA, LLC
$156
Pulmonx Corporation
$144
Sunovion Pharmaceuticals Inc.
$123
Novartis Pharmaceuticals Corporation
$63
Shire North American Group Inc
$44
PFIZER INC.
$42
Regeneron Healthcare Solutions, Inc.
$36
Tactile Systems Technology Inc
$33
Fisher & Paykel Healthcare Inc
$32
Bayer Healthcare Pharmaceuticals Inc.
$23
Electromed, Inc.
$20
Amgen Inc.
$19
JAZZ PHARMACEUTICALS INC.
$18
Janssen Pharmaceuticals, Inc
$18
Insmed, Inc.
$16
Mallinckrodt Hospital Products Inc.
$15
Jazz Pharmaceuticals Inc.
$15
Breathe Technologies, Inc.
$11
Ambu Inc.
$10
Top 3 companies account for 92.2% of total payments
Associated products mentioned in payments ›
(2809) Trilogy 100 · (8874) inCourage · ACTHAR · ANORO · ANORO ELLIPTA · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · CHANTIX · CHARTIS CATHETER · DUPIXENT · Da Vinci Surgical System · Esbriet · FASENRA · FISHER & PAYKEL HEALTHCARE · Flexitouch Plus · GLASSIA · LIFE2000 · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · TEZSPIRE · TRELEGY ELLIPTA · UPTRAVI · Utibron · XARELTO · XOLAIR · XYREM · Xolair · ZEPHYR DELIVERY CATHETER · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for pulmonary disease in FL.

Equivalent to $1,441 per 100 Medicare services performed
Looking for a pulmonary disease in Ocala?
Compare pulmonary diseases in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
9
Per 100K population
2.3
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kohli is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 10%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kohli experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Kohli performed 310 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kohli receive payments from pharmaceutical companies?
Yes. Dr. Kohli received a total of $24,885 from 27 companies across 287 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kohli's costs compare to other pulmonary diseases in Ocala?
Dr. Kohli's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kohli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →